|

anti-PD-1/anti-PD-L1 antibody Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • The Second Affiliated Hospital of Chongqing Medical University1

Indications

  • Anti-PD-L1 Antibody1
  • Peg-IFNα1
  • Liver Disease1
  • Anti-PD-1 Antibody1
  • Chronic Hepatitis b1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.